专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20060121958A1 Wearable mobile phone using EMG and controlling method thereof 有权
公开(公告)号：US20060121958A1
公开(公告)日：2006-06-08
申请号：US11132333
申请日：2005-05-19
申请人： Joon Jung , Yun Park , Jeun Lee
发明人： Joon Jung , Yun Park , Jeun Lee
IPC分类号： H04B1/38
CPC分类号： H04M1/0202 , G06F3/015 , H04B1/385 , H04B2001/3866 , H04M1/23 , H04M2250/12
摘要： Disclosed are a wearable mobile phone capable of detecting EMG changed by hand motion of a user and a control method of an input unit of the wearable mobile phone. The wearable mobile phone includes an EMG measuring unit 10 having a plurality of EMG measuring sensors 11 for detecting the EMG changed by hand motion of a user, and made in a ring shape to be worn on a wrist of the user, an EMG transferring unit 20 connected to the EMG measuring unit 10 for transferring the EMG measured by the EMG measuring unit, an EMG determining unit 30 mounted to one side of the EMG transferring unit 20 for receiving EMG from the EMG transferring unit to determine the hand motion and extract an input signal for the mobile phone corresponding to the hand motion, and a mobile phone functioning unit 40 receiving the input signal from the EMG determining unit for functioning the mobile function and having an antenna and a sound transferring device. The wearable mobile phone allows the user to input wanted information related to operation of the mobile phone, without using input keys, which can miniaturize the mobile phone and easily carry the mobile phone.

2. 发明申请

US20060199821A1 Heterocyclic amides and sulfonamides 审中-公开
标题翻译：杂环酰胺和磺酰胺
公开(公告)号：US20060199821A1
公开(公告)日：2006-09-07
申请号：US11196650
申请日：2005-08-03
申请人： Richard Tester , Xuefei Tan , Kurt Schinzel , Imad Nashashibi , Gregory Luedtke , Weiling Liang , Joon Jung , R. Goehring , Sundeep Dugar , Steven Do
发明人： Richard Tester , Xuefei Tan , Kurt Schinzel , Imad Nashashibi , Gregory Luedtke , Weiling Liang , Joon Jung , R. Goehring , Sundeep Dugar , Steven Do
IPC分类号： A61K31/5377 , A61K31/53 , A61K31/513 , A61K31/506 , C07D413/02 , C07D403/02 , C07D405/02
CPC分类号： C07D405/12 , C07D213/75 , C07D239/48 , C07D401/12 , C07D405/14 , C07D409/12 , C07D417/12
摘要： The invention is directed to compounds and methods to inhibit p38 kinase wherein the compounds are a pyrimidine or pyridine coupled to two mandatory substituents.
摘要翻译：本发明涉及抑制p38激酶的化合物和方法，其中化合物是与两个强制性取代基偶联的嘧啶或吡啶。

3. 发明申请

US20140228358A1 ACYCLIC CYANOETHYLPYRAZOLES AS JANUS KINASE INHIBITORS 有权
标题翻译： ACYCLIC CYANOETHYLZOLES作为JANUS KINASE INHIBITORS
公开(公告)号：US20140228358A1
公开(公告)日：2014-08-14
申请号：US14345977
申请日：2012-09-21
申请人： Jason Brubaker , Joshua T. Close , Joon Jung , Michelle Martinez , Catherine White , Kevin Wilson , Jonathan R. Young , Hongjun Zhang
发明人： Jason Brubaker , Joshua T. Close , Joon Jung , Michelle Martinez , Catherine White , Kevin Wilson , Jonathan R. Young , Hongjun Zhang
IPC分类号： C07D231/38 , C07D403/06 , C07D401/14 , C07D405/06 , C07D401/12 , C07D401/06 , C07D403/12
CPC分类号： C07D405/08 , C07D231/38 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/06 , C07D403/08 , C07D403/12 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/14
摘要： The instant invention provides compounds of formula I which are JAK inhibitors, and as such are useful for the treatment of JAK-mediated diseases such as rheumatoid arthritis, asthma, COPD and cancer.
摘要翻译：本发明提供了作为JAK抑制剂的式I化合物，因此可用于治疗JAK介导的疾病如类风湿性关节炎，哮喘，COPD和癌症。

4. 发明授权

US08455477B2 Therapeutic compounds 失效
标题翻译：治疗化合物
公开(公告)号：US08455477B2
公开(公告)日：2013-06-04
申请号：US13057325
申请日：2009-07-27
申请人： Jason Katz , James Jewell , Joon Jung , Solomon Kattar , Yongquan Hou , Rachel MacCoss , Satoru Ito
发明人： Jason Katz , James Jewell , Joon Jung , Solomon Kattar , Yongquan Hou , Rachel MacCoss , Satoru Ito
IPC分类号： A61K31/437 , A61K31/438 , A61K31/4439 , A61K31/444 , A61K31/5377 , A61K31/397 , A61K31/505 , A61K31/495 , A61K31/496 , A61K31/50 , C07F7/02 , C07D487/02 , C07D413/14 , C07D401/02 , C07D401/14 , C07D221/20
CPC分类号： A61K45/06 , A61K31/535 , C07D471/04 , C07D519/00 , A61K2300/00
摘要： The present invention relates to pyrazolopyridines and imidazopyridines which are inhibitors of the kinase PDK1 and are thus useful for the treatment of myeloproliferative disorders or cancer. The compounds are also useful as inhibitors of other kinases such as FGFR3, NTRK3, RP-S6K and WEE1. Furthermore, the present compounds also selectively inhibit microtubule affinity regulating kinase (MARK) and are therefore useful for the treatment or prevention of Alzheimer's disease.
摘要翻译：本发明涉及作为激酶PDK1的抑制剂的吡唑并吡啶和咪唑并吡啶，因此可用于治疗骨髓增生性疾病或癌症。该化合物也可用作其它激酶如FGFR3，NTRK3，RP-S6K和WEE1的抑制剂。此外，本发明化合物还选择性地抑制微管亲和调节激酶（MARK），因此可用于治疗或预防阿尔茨海默氏病。

5. 发明申请

US20100210623A1 THERAPEUTIC COMPOUNDS 有权
标题翻译：治疗化合物
公开(公告)号：US20100210623A1
公开(公告)日：2010-08-19
申请号：US12682612
申请日：2008-10-21
申请人： David J. Guerin , Joon Jung , Elizabeth Stanton
发明人： David J. Guerin , Joon Jung , Elizabeth Stanton
IPC分类号： A61K31/337 , C07D403/14 , A61K31/496 , C07D205/04 , A61P35/00
CPC分类号： C07D471/04
摘要： The present invention relates to pyrazine substituted pyrrolopyridines which are inhibitors of JAK kinases (JAK1, JAK2, JAK3 and/or TYK2) and/or PDK1 and are thus useful for the treatment of myeloproliferative disorders or cancer.
摘要翻译：本发明涉及作为JAK激酶（JAK1，JAK2，JAK3和/或TYK2）和/或PDK1的抑制剂的吡嗪取代的吡咯并吡啶，因此可用于治疗骨髓增生性疾病或癌症。

6. 发明申请

US20060049013A1 Integrated suspension system for vehicle 有权
标题翻译：车辆集成悬挂系统
公开(公告)号：US20060049013A1
公开(公告)日：2006-03-09
申请号：US11006673
申请日：2004-12-08
申请人： Joon Jung
发明人： Joon Jung
IPC分类号： F16F9/14
CPC分类号： F16F9/0218 , B60G17/0416 , B60G2202/152 , B60G2500/20 , F16F9/3405 , F16F9/44
摘要： An integrated suspension system includes a cylinder that hermetically contains gas therein and is fixed to a vehicle body; a piston that has a motor at an upper portion thereof, is configured to support a road wheel and is guided within the cylinder to move vertically; a disk unit including a second disk that has a plurality of passage holes formed there through and a bottom surface coupled to a driving shaft of the motor to rotate while moving vertically integrally along with the piston, and a first disk that has a plurality of passage holes and is stacked on and connected via a hinge to the center of a top surface of the second disk to move vertically within the cylinder integrally along with the second disk without any rotation; and a control unit that controls an opening degree established through overlap of the passage holes formed in the first and second disks by changing power supplied to the motor to control a rotational angle of the second disk.
摘要翻译：一体式悬架系统包括：气瓶，其气密地包含气体并固定在车体上; 在其上部具有电动机的活塞被构造成支撑路轮并且在气缸内被引导以垂直移动; 一个盘单元，包括第二盘，其具有形成在其上的多个通道孔和与驱动轴连接的底表面，该底表面与所述活塞一起垂直地一体地旋转;以及第一盘，其具有多个通道并且通过铰链堆叠并连接到第二盘的顶表面的中心，以在圆筒内与第二盘一体地垂直地移动而没有任何旋转; 以及控制单元，其通过改变供给到所述电动机的电力来控制形成在所述第一和第二盘中的通路的重叠而建立的开度，以控制所述第二盘的旋转角度。

7. 发明授权

US08962608B2 Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors 有权
标题翻译：环烷基腈吡唑甲酰胺作为甘蔗激酶抑制剂
公开(公告)号：US08962608B2
公开(公告)日：2015-02-24
申请号：US14345976
申请日：2012-09-21
申请人： Jason Brubaker , Christopher Dinsmore , Dawn Marie Hoffman , Joon Jung , Duan Liu , Scott Peterson , Tony Siu , Luis E. Torres , Hongjun Zhang , Zhongyong Wei , Feng Shi
发明人： Jason Brubaker , Christopher Dinsmore , Dawn Marie Hoffman , Joon Jung , Duan Liu , Scott Peterson , Tony Siu , Luis E. Torres , Hongjun Zhang , Zhongyong Wei , Feng Shi
IPC分类号： A61K31/397 , A61K31/5377 , A61K31/501 , A61K31/497 , A61K31/415 , C07D231/38 , C07D403/08 , C07D403/12 , C07D405/08 , C07D401/12 , C07D401/14 , C07D405/12 , C07D409/12 , C07D413/12 , C07D401/04 , C07D403/04 , C07D405/04 , C07D401/06 , C07D403/06 , C07D405/06 , C07D405/14 , C07D409/04 , C07D413/14 , C07D417/14
CPC分类号： C07D405/08 , C07D231/38 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/06 , C07D403/08 , C07D403/12 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/14
摘要： The instant invention provides compounds of formula I which are JAK inhibitors, and as such are useful for the treatment of JAK-mediated diseases such as rheumatoid arthritis, asthma, COPD and cancer.
摘要翻译：本发明提供了作为JAK抑制剂的式I化合物，因此可用于治疗JAK介导的疾病如类风湿性关节炎，哮喘，COPD和癌症。

8. 发明授权

US09493441B2 Acyclic cyanoethylpyrazoles as janus kinase inhibitors 有权
标题翻译：无环氰基乙基吡唑作为甘蔗激酶抑制剂
公开(公告)号：US09493441B2
公开(公告)日：2016-11-15
申请号：US14345977
申请日：2012-09-21
申请人： Jason Brubaker , Joshua T. Close , Joon Jung , Michelle Martinez , Catherine White , Kevin Wilson , Jonathan R. Young , Hongjun Zhang
发明人： Jason Brubaker , Joshua T. Close , Joon Jung , Michelle Martinez , Catherine White , Kevin Wilson , Jonathan R. Young , Hongjun Zhang
IPC分类号： C07D405/08 , C07D403/12 , C07D401/14 , C07D231/38 , C07D401/12 , C07D403/08 , C07D405/12 , C07D409/12 , C07D413/12 , C07D401/04 , C07D403/04 , C07D405/04 , C07D401/06 , C07D403/06 , C07D405/06 , C07D405/14 , C07D409/04 , C07D413/14 , C07D417/14
CPC分类号： C07D405/08 , C07D231/38 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/06 , C07D403/08 , C07D403/12 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/14
摘要： The instant invention provides compounds of formula I which are JAK inhibitors, and as such are useful for the treatment of JAK-mediated diseases such as rheumatoid arthritis, asthma, COPD and cancer.
摘要翻译：本发明提供了作为JAK抑制剂的式I化合物，因此可用于治疗JAK介导的疾病如类风湿性关节炎，哮喘，COPD和癌症。

9. 发明授权

US09328099B2 Cyanomethylpyrazole carboxamides as janus kinase inhibitors 有权
标题翻译：氰基甲基吡唑甲酰胺作为甘蔗激酶抑制剂
公开(公告)号：US09328099B2
公开(公告)日：2016-05-03
申请号：US14345978
申请日：2012-09-21
申请人： Jason Brubaker , Matthew Lloyd Childers , Matthew Christopher , Joshua T. Close , Jason David Katz , Joon Jung , Scott Peterson , Phieng Siliphaivanh , Tony Siu , Graham Frank Smith , Luis E. Torres , Hyun Chong Woo , Jonathan R. Young , Hongjun Zhang
发明人： Jason Brubaker , Matthew Lloyd Childers , Matthew Christopher , Joshua T. Close , Jason David Katz , Joon Jung , Scott Peterson , Phieng Siliphaivanh , Tony Siu , Graham Frank Smith , Luis E. Torres , Hyun Chong Woo , Jonathan R. Young , Hongjun Zhang
IPC分类号： C07D231/38 , C07D405/04 , C07D401/14 , C07D401/04 , C07D403/04 , C07D405/08 , C07D403/12 , C07D401/12 , C07D403/08 , C07D405/12 , C07D409/12 , C07D413/12 , C07D401/06 , C07D403/06 , C07D405/06 , C07D405/14 , C07D409/04 , C07D413/14 , C07D417/14
CPC分类号： C07D405/08 , C07D231/38 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/06 , C07D403/08 , C07D403/12 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/14
摘要： The instant invention provides compounds of formula I which are JAK inhibitors, and as such are useful for the treatment of JAK-mediated diseases such as rheumatoid arthritis, asthma, COPD and cancer.
摘要翻译：本发明提供了作为JAK抑制剂的式I化合物，因此可用于治疗JAK介导的疾病如类风湿性关节炎，哮喘，COPD和癌症。

10. 发明授权

US08604038B2 Pyrrolidine derived beta 3 adrenergic receptor agonists 有权
标题翻译：吡咯烷衍生的β3肾上腺素能受体激动剂
公开(公告)号：US08604038B2
公开(公告)日：2013-12-10
申请号：US13392282
申请日：2010-08-24
申请人： Scott D. Edmondson , Lehua Chang , Nam Fung Kar , Gergori J. Morriello , Christopher R. Moyes , Dong-Ming Shen , Cheng Zhu , Neville J. Anthony , Philip Jones , Graham F. Smith , Mark E. Scott , Christopher F. Thompson , Joon Jung , Carolyn Cammarano , Dawn Marie Hoffman
发明人： Scott D. Edmondson , Lehua Chang , Nam Fung Kar , Gergori J. Morriello , Christopher R. Moyes , Dong-Ming Shen , Cheng Zhu , Neville J. Anthony , Philip Jones , Graham F. Smith , Mark E. Scott , Christopher F. Thompson , Joon Jung , Carolyn Cammarano , Dawn Marie Hoffman
IPC分类号： A61K31/50 , A61K31/525
CPC分类号： C07D401/12 , C07D207/08 , C07D403/12 , C07D413/12 , C07D417/12 , C07D471/04
摘要： The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
摘要翻译：本发明提供式（I）的化合物，其药物组合物及其用于治疗或预防由β3肾上腺素受体激活介导的疾病的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式